The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

Background There is an urgent need for novel, noninvasive biomarkers to diagnose Alzheimer’s disease (AD) in the predementia stages and to predict the rate of decline. Therefore, we set up the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery (EMIF-AD MBD)...

Full description

Saved in:
Bibliographic Details
Published in:Alzheimer's research & therapy Vol. 10; no. 1; pp. 64 - 9
Main Authors: Bos, Isabelle, Vos, Stephanie, Vandenberghe, Rik, Scheltens, Philip, Engelborghs, Sebastiaan, Frisoni, Giovanni, Molinuevo, José Luis, Wallin, Anders, Lleó, Alberto, Popp, Julius, Martinez-Lage, Pablo, Baird, Alison, Dobson, Richard, Legido-Quigley, Cristina, Sleegers, Kristel, Van Broeckhoven, Christine, Bertram, Lars, ten Kate, Mara, Barkhof, Frederik, Zetterberg, Henrik, Lovestone, Simon, Streffer, Johannes, Visser, Pieter Jelle
Format: Journal Article
Language:English
Published: London BioMed Central 06.07.2018
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects:
ISSN:1758-9193, 1758-9193
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first